14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:INFI
Delisted

Infinity Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0160
+0 (+0%)
At Close: Dec 28, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0160 $0.0160 Thursday, 28th Dec 2023 INFI stock ended at $0.0160. During the day the stock fluctuated 0% from a day low at $0.0160 to a day high of $0.0160.
90 days $0.0115 $0.0190
52 weeks $0.0111 $0.770

Historical Infinity Pharmaceuticals prices

Date Open High Low Close Volume
Mar 14, 2023 $0.190 $0.200 $0.180 $0.190 828 787
Mar 13, 2023 $0.185 $0.195 $0.175 $0.189 801 164
Mar 10, 2023 $0.203 $0.203 $0.173 $0.195 2 815 912
Mar 09, 2023 $0.212 $0.220 $0.202 $0.206 664 323
Mar 08, 2023 $0.222 $0.230 $0.210 $0.212 850 938
Mar 07, 2023 $0.232 $0.237 $0.220 $0.221 729 826
Mar 06, 2023 $0.232 $0.237 $0.220 $0.235 1 300 589
Mar 03, 2023 $0.250 $0.250 $0.232 $0.236 1 098 815
Mar 02, 2023 $0.226 $0.250 $0.209 $0.240 2 131 195
Mar 01, 2023 $0.220 $0.253 $0.218 $0.230 1 497 179
Feb 28, 2023 $0.241 $0.250 $0.212 $0.214 2 094 986
Feb 27, 2023 $0.240 $0.260 $0.234 $0.242 1 956 063
Feb 24, 2023 $0.280 $0.284 $0.232 $0.243 4 301 377
Feb 23, 2023 $0.378 $0.380 $0.280 $0.281 12 897 308
Feb 22, 2023 $0.550 $0.580 $0.530 $0.550 141 410
Feb 21, 2023 $0.590 $0.600 $0.512 $0.539 534 786
Feb 17, 2023 $0.580 $0.590 $0.560 $0.573 259 351
Feb 16, 2023 $0.572 $0.603 $0.553 $0.573 380 874
Feb 15, 2023 $0.600 $0.627 $0.571 $0.590 360 554
Feb 14, 2023 $0.580 $0.600 $0.575 $0.590 192 589
Feb 13, 2023 $0.600 $0.620 $0.572 $0.594 260 701
Feb 10, 2023 $0.596 $0.615 $0.560 $0.601 317 392
Feb 09, 2023 $0.615 $0.615 $0.566 $0.571 444 534
Feb 08, 2023 $0.611 $0.620 $0.600 $0.605 269 411
Feb 07, 2023 $0.625 $0.650 $0.609 $0.622 190 478
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT